Midwest Center for Reproductive Health (MCRH), located at 12000 Elm Creek Blvd N in Maple Grove, Minnesota, serves patients in the northwest Twin Cities suburbs and the broader Minnesota fertility care market. Maple Grove is a rapidly growing suburban community in Hennepin County, situated approximately 20 miles northwest of downtown Minneapolis along I-94 and I-694. The Elm Creek Blvd N address is in Maple Grove's major commercial and medical corridor, accessible from patients in Plymouth, Osseo, Brooklyn Park, Rogers, Champlin, and other northwest metro communities. Minnesota patients can explore the full Minnesota fertility clinic directory.
Physicians and Clinical Team
MCRH is led by board-certified reproductive endocrinologists with fellowship training from ACGME-accredited programs. The practice has established itself as a significant independent provider in the Twin Cities fertility market, which also includes academic programs at the University of Minnesota and practices affiliated with large health systems including M Health Fairview and Allina Health. Fellowship-trained REIs at MCRH hold ABOG subspecialty board certification and bring comprehensive expertise in ovulation disorders, endometriosis, male-factor infertility, recurrent pregnancy loss, and advanced ART protocols.
The clinical team includes reproductive nurses who guide patients through stimulation and monitoring cycles, ultrasonographers experienced in reproductive assessment, embryologists who manage the in vitro phase of IVF, and patient care coordinators who assist with scheduling, insurance verification, and financial planning. Maple Grove's northwest suburban location is convenient for a patient base that values the combination of high-quality specialty care and accessible suburban logistics — ample parking, proximity to major highways, and a lower-stress clinical environment than urban hospital campuses.
Services and Treatments
MCRH offers a comprehensive range of reproductive medicine services, including:
- Comprehensive fertility consultation and diagnostic evaluation
- Ovarian reserve assessment (AMH, antral follicle count, FSH, estradiol)
- Semen analysis and male-factor evaluation
- Ovulation induction with oral and injectable medications
- Cycle monitoring with ultrasound and bloodwork
- Intrauterine insemination (IUI)
- In vitro fertilization (IVF) — see also our IVF guide
- Intracytoplasmic sperm injection (ICSI)
- Preimplantation genetic testing (PGT-A, PGT-M)
- Frozen embryo transfer (FET)
- Egg freezing and embryo banking
- Donor sperm coordination with licensed banks
- Donor egg program
- Gestational carrier support
- Recurrent pregnancy loss evaluation and management
- Hormonal and endocrine disorder evaluation
Laboratory and Success Rates
MCRH's IVF laboratory operates under Minnesota Department of Health oversight and federal CLIA requirements. The laboratory handles the complete in vitro phase: egg maturity grading, fertilization (conventional and ICSI), extended culture through blastocyst, blastocyst grading, biopsy for PGT when elected, and vitrification. Modern vitrification protocols have substantially improved frozen embryo transfer outcomes, making embryo banking for future cycles a reliable and increasingly common treatment strategy.
Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
Maple Grove has grown to become one of the Twin Cities' largest and most prosperous northwest suburbs, with excellent schools, extensive retail and dining, and strong transit connections via I-94 and I-694. The 12000 Elm Creek Blvd N address is close to the Maple Grove hospital campus (North Memorial Health) and within easy reach of the northwest metro's growing residential neighborhoods. Patients from Rogers, Champlin, Brooklyn Park, Corcoran, and Dayton are all well-positioned for this clinic, as are patients from the north and northeast metro who prefer this location over commuting south to Minneapolis or to practices further downtown.
The Twin Cities metro is one of the Midwest's most culturally diverse markets, with significant Somali, Hmong, Latinx, East African, and South Asian communities, as well as the country's largest urban American Indian population. A fertility practice serving northwest metro Minneapolis should be prepared to engage respectfully and effectively with patients from these communities, providing language access resources and culturally sensitive care protocols as appropriate. The Maple Grove area skews more white and affluent than the broader metro, but the catchment area includes more diverse communities in Brooklyn Center, Brooklyn Park, and north Minneapolis.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Minnesota does not have a state-mandated infertility insurance benefit. The Twin Cities metro includes several large employers — Target, Best Buy, 3M, UnitedHealth Group, Medtronic, and major health systems — some of which have added voluntary fertility benefits in recent years. However, coverage remains uneven, and many Minnesota patients will face largely out-of-pocket costs for fertility treatment.
Out-of-pocket IVF costs in the Twin Cities area typically range from $12,000–$16,000 per fresh retrieval cycle before medications, with medications adding $3,000–$5,000. MCRH's financial team can assist with insurance benefits verification and cost planning. Third-party healthcare financing through lenders such as CapexMD and Prosper Healthcare Lending is commonly used by Minnesota fertility patients. Pharmaceutical manufacturer assistance programs may reduce medication costs for qualifying patients. Patients with HSA or FSA accounts can often use pre-tax dollars for qualified fertility-related medical expenses, which can meaningfully reduce the effective cost of diagnostic testing and some procedures.
Frequently Asked Questions
Is Maple Grove a reasonable commute for patients in downtown Minneapolis? From downtown Minneapolis, the drive to Maple Grove is typically 25–35 minutes on I-94 West to I-694 North during off-peak hours. During peak commute times, the drive may take 40–55 minutes. For patients who prefer suburban convenience — ample parking, shorter wait times, a quieter environment — the suburban Maple Grove location is a reasonable trade-off for the distance.
How does MCRH compare to academic fertility programs at the University of Minnesota? MCRH operates as an independent private practice, while the University of Minnesota's reproductive medicine program is embedded in an academic medical center. The key differences are the academic program's research integration and access to a broader range of subspecialty resources versus the independent practice's typically more focused patient-care orientation and potentially shorter wait times. For complex cases requiring multidisciplinary input, the academic environment may offer advantages; for patients seeking a more personalized private practice experience, an independent practice like MCRH may be preferable.
What should I expect at my first fertility appointment? The initial consultation at MCRH typically includes a detailed medical history review, a discussion of your fertility history and goals, and the ordering of baseline diagnostic tests — typically including a transvaginal ultrasound (antral follicle count, uterine anatomy assessment) and a hormone panel (AMH, FSH, LH, estradiol). For patients in a partnership, a semen analysis is typically ordered simultaneously. Results are reviewed at a follow-up appointment where a treatment plan is developed.
Does MCRH offer genetic counseling for patients who want carrier screening? Carrier screening — testing to determine whether one or both partners carry genetic variants that could be passed to a child — is increasingly routine in fertility care and can be coordinated through or alongside MCRH. Genetic counselors can assist with interpretation of carrier screening results and with decisions about PGT-M (testing embryos for a specific inherited condition). Patients with a family history of genetic disorders should specifically ask about carrier screening during their consultation.